Our data support the notion that the tumor microenvironment, in combination with serum, stimulates CSCs to secrete cytokines, such as IL-6 and CCL2, that act paracrine to cancer cells to enhance their malignant properties, including sphere formation, stem cell characteristics, and migration ability [54]. The gene discussed is CCL2; the disease is cancer.